InVivo Therapeutics Announces FDA Approval to Expedite Enrollment for Ongoing Pilot Trial | 7:22 AM |
[at noodls] - CAMBRIDGE, Mass. (Dec 16, 2014) - InVivo Therapeutics Holdings Corp. (NVIV) today announced approval by the U.S. Food and Drug Administration (FDA) for an expedited enrollment plan for the company's ongoing ...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.